- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 30, 2024 | 2.55M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $136K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $95K |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $7.61M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $7.93M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $29.09M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $29.57M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $35.99M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $36.59M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.16 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.63 |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 2.48M sh |
| Capex restated | Q1 2024 · Mar 31, 2023 | $299K |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $33.62M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $35.11M |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.63 |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $2.19M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$1.55M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$1.2M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $988K |